The ixLayer platform has been adapted to deliver and scale COVID-19 testing. ixLayer powers health systems and individual physicians with the tools they need to order testing on patients.
ixlayer’s COVID-19 clinical testing platform offers a scalable solution to move labs from assay validation to launch in record time.
If clinical laboratories have their assay validated, interfacing the ixlayer platform with their LIMS can likely be finalized within 48h. This rapid production is critical for meeting the ever-growing demand for COVID-19 testing and is delivered while also including best-in-class quality throughout the user experience, security, and scalability.
Ixlayer is a first-of-its-kind platform offering laboratory patient and physician facing solutions.The HIPAA-compliant Cloud platform integrates with the needed steps and services to launch tests professionally, effectively, and what is also important in today’s climate – Quickly & Efficiently.
Clinical labs can focus on scaling their testing and rapidly delivering results, and ixlayer will take care of patient pre-screening, physician orders, logistics, coordinated sample collections, at-home sample collections, real-time result delivery, and triaging patients to the right care.
The COVID-19 clinical testing website, built on the ixlayer platform, provides patients with current guidelines from the Centers for Disease Control and World Health Organization throughout the testing flow. The content, written and reviewed by physicians, and experts in health education, cytogenetics, and patient experience.
The ixLayer platform provides COVID-19 ordering solutions for primary care physicians and it also integrates into Telemedicine physician networks, with doctors located in all 50 states.
Clinical results need physician approval and sign off in order to release the data to participants. Ixlayer integration with physician networks enables frictionless automated process to scale the study.
Ixlayer enables physician led communication and follow up for positive/abnormal results. This enables patients to find local providers or specialist and coordinates smooth transition into local care.
The ixlayer platform, already being used by several national labs and healthcare groups to offer genetic and precision health testing, now connects the pieces needed to scale COVID-19 testing, including connecting organizations and universities, healthcare systems and physicians, and clinical laboratories.
Quickly identify patients who need to stay home, track positive cases and the spread of viruses or infectious diseases. Help patients self quarantine by bringing care directly to their own home. Keep sick patients out of hospitals and urgent care centers, get results quickly.
Whether an individual healthcare provider or a large healthcare system is looking for COVID-19 testing solutions, the ixlayer platform allows physicians to easily offer telehealth services to pre-screen their patients, order the test, and get result delivery.Contact us for more info
The ixLayer platform is integrated to all of the key services needed to successfully launch at home testing quickly. From kit logistics and shipping, to physician groups, to laboratories, ixLayer takes care of everything.Contact us for more info
A key component to understanding the spread of COVID-19 is the ability to test people and then track the test results in conjunction with patient symptoms.
The ixlayer platform powers metrics that can be broken into sub-categories that can report collectively or independently age and gender, pre-test symptoms, positive and negative results, and geographic location.
Through both charts and mapping, the ixlayer platform can create modeling tools needed by organizations like the CDC and research groups to track the spread of COVID-19 between communities and identify the most impacted demographic groups. The ixlayer platform is not limited to tracking testing companies independently, but rather can report on numerous test suppliers simultaneously, allowing a centralized data set and modeling structure.